SCHEMBL5482854

SCHEMBL5482854

CC(C)CNC(=O)c1ccc(-c2cccc(C(N)=O)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.61
KMT2A Q03164 1/20 0.61
HSD17B10 Q99714 1/20 0.61
F10 P00742 5/20 0.52
PLG P00747 2/20 0.52
PROC P04070 1/20 0.52
F3 P13726 3/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HPGDS O60760 1/20 0.51
CTSS P25774 1/20 0.51
CTSK P43235 1/20 0.51
PRSS1 P07477 3/20 0.50
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49
F2 P00734 1/20 0.49
F7 P08709 1/20 0.49
FYN P06241 1/20 0.49
ADAMTS4 O75173 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6273049 0.95 GAA (0.66) GAAKMT2AHSD17B10F10PLG
SCHEMBL31331780 0.84 GAA (0.76) GAAKMT2AHSD17B10NPC1RAB9A
SCHEMBL1928381 0.84 GAA (0.76) GAAKMT2AHSD17B10NPC1RAB9A
SCHEMBL18082335 0.82 NPC1 (0.71) GAAKMT2AHSD17B10NPC1RAB9A
SCHEMBL3023796 0.80 GAA (0.73) GAAKMT2AHSD17B10SMN1; SMN2HPGD
SCHEMBL14507774 0.80 PLAU (0.54) F10PLGPROCNPC1RAB9A
SCHEMBL16105693 0.79 KMT2A (0.67) GAAKMT2AHSD17B10F10F3
SCHEMBL13702344 0.79 AOC3 (0.54) F10PLGPROCSMN1; SMN2HPGD
SCHEMBL3634634 0.78 MLYCD (0.58) GAAKMT2AHSD17B10NPC1RAB9A
SCHEMBL3454176 0.77 KMT2A (0.59) GAAKMT2AHSD17B10F10F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070129354-A1 Biphenyl carboxylic amide p38 kinase inhibitors GLAXOSMITHKLINE LLC 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129354-A1 Biphenyl carboxylic amide p38 kinase inhibitors MAPK1, MAPKAPK2, MAPK7 GAA 2260/4885KMT2A 1855/4885HSD17B10 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.